Tri-Cira Lo 21 0.25 mg

TRI-CIRA LO 21 0.25 MG tablets contain norgestimate, a progestin used for hormonal contraception. This oral medication is designed to prevent ovulation and is available in a 21-day pack.

TRI-CIRA LO 21 0.25 MG tablets are primarily used for birth control. The active ingredient, norgestimate, works by preventing ovulation and altering the cervical mucus to hinder sperm movement. This medication is part of a combined oral contraceptive regimen, typically taken for 21 consecutive days followed by a 7-day break. It is important to follow the prescribed schedule for effective contraception.

Common effects of TRI-CIRA LO 21 0.25 MG tablets may include changes in menstrual bleeding patterns, such as lighter or shorter periods. Some users may experience nausea, breast tenderness, or headaches. These effects vary among individuals and are generally mild. If any effects persist or worsen, it is advisable to consult a healthcare provider.

TRI-CIRA LO 21 0.25 MG tablets should be stored at room temperature, away from moisture and heat. Keep the medication out of reach of children and pets. It is important to follow the prescribed dosage and schedule. Do not use this medication if you are allergic to norgestimate or any of its components. Inform your healthcare provider about any medical conditions or medications you are currently taking.

TRI-CIRA LO 21 0.25 MG tablets may interact with certain medications, including antibiotics, anticonvulsants, and HIV medications. These interactions can affect the effectiveness of the contraceptive. Alcohol consumption should be moderated, as it may exacerbate certain side effects. Always consult a healthcare provider before starting or stopping any medication while using TRI-CIRA LO 21 0.25 MG tablets.